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of this resistance may illuminate critical sites
of the cell-carcinogen interaction.
Cells treated in vitro with N-methyl-N-
nitrosourea, MNU, exhibited malignant trans-
formation and were ten-fold more resistant
to MNU toxicity than previously treated
normal cells. Transformation and resistance
were related and dose dependent. MNU
resistant cells were twice as resistant to
methyl methanesulphonate toxicity and ten-
fold more resistant to the toxic effect of
thymidine, compared wvith normal cells.
Resistance to MNU and thymidine could
not be explained by reduced incorporation,
as measured by the uptake of the respective
radioactively labelled compound. The cross
resistance suggested similar sites may be
involved in MNU and thymidine toxicity.
(Studies performed at the Paterson Labora-
tories, Christie Hospital, Manchester.)
INHIBITION OF THE EFFECTS OF
METHYLCHOLANTHRENE BY VITA-
MIN A AND VITAMIN A ANALOGUES,
Ilse Lasnitzki and De Witt S. Goodman,
Strangeways Research Laboratory, Cam-
bridge.
Retinol and retinoic acid have been shown
to inhibit carcinogenesis in vitro and in vivo
but their possible clinlical use may be limited
by their high toxicity. Vitamin A analogues
without the biological properties of the
natural vitamin may serve as substitutes.
The influence of two analogues, ox-retinoic
acid and anhydroretinoic acid, on the effect
of methylcholanthrene was examined in
mouse prostates grown in vitro and compared
with that of retinol and retinoic acid.
The carcinogen alone induced extensive
epithelial hyperplasia and dysplasia. All
four compounds, applied at various dose
levels, were highly active in inhibiting this
effect. At the highest concentration they
almost totally suppressed the hyperplasia, at
the lowest concentration retinoic acid and
anhydroretinoic acid were the most effective
inhibitors. Mechanisms involved in the
antagonism have been investigated.
IMMUNOGENICITY OF EMBRYONIC
ANTIGENS ASSOCIATED WITH
CHEMICALLY INDUCED RAT TU-
MOURS, R. W. Baldwin and B. M. Vose,
Cancer Research Laboratories, University of
Nottingham.
Chemically induced rat hepatomata and
sarcomata express neoantigens at the cell
surface which are also detectable on mid-
gestation rat embryo cells. These antigens
are revealed by the cytotoxicity ofserum and
lymph node cells from multiparous female
rats for embryo and tumour cells by serum
from these animals. Since the multiparous
rat becomes sensitized to these antigens, they
are immunogenic when expressed on embryo
cells in the pregnant host. Immunization of
syngeneic rats with mid-gestation rat emblryo
cells failed, however, to elicit immunity to
challenge with hepatomata or sarcomata.
Also, lymphoid cells from multiparous rats
were ineffective for adoptively transferring
tumour immunity. These studies are dis-
cussed in connection with the view that the
tumour specific rejection antigens on these
tumours differ from the tumour associated
embryonic antigens.
"WILD" TYPE ANTIGENS OF SAR-
COMATA INDUCED BY A NATURAL
AMINE SARCOMA VIRUS (MSV-FBJ),
David B. Jones and Michael Moore, Charles
Salt Research Centre, The Robert Jones and
Agnes Hunt Orthopaedic Hospital, Oswestry.
MSV-FBJ is a C-type murine oncorna-
virus which induces primitive mesenchymal
sarcomata of long latency in mice. The
agent was originally isolated from a sponta-
neous murine osteosarcoma and is of demon-
strated " wild " type antigencity.
Transplantation rejection techniques have
demonstrated a tumour associated antigen
common to all cells transformed by MSV-FBJ
and also present on cells infected with " wild "
type Gross leukaemia virus. The specificity
was absent from cells transformed by the
" non-wild " type isolate MSV-Harvey (MSV-
H).
Serum from mice immunized against
MSV-FBJ sarcoma cells reacted in the
indirect membrane immunofluorescence test
with both MSV-FBJ sarcoma cells and Gross
antigen bearing cells, but not with the
membrane of MSV-H cells. Further, aged
C57B1 serum specifically reactivewithcellular
rather than virion specificities of Gross virus
infected cells reacted with MSV-FBJ sarcoma
cells. Identification ofantigens onthe surface
of MSV-FBJ sarcoma cells which were not
also present on " wild " type antigen-bearing
tumours could not be achieved by absorption
techniques.B.A.C.R. AUTUMN MEETING 95
By complement fixation, murine oncorna-
virus group specific antigen was identified in
crude extracts of MSV-FBJ sarcomata to-
getherwithsolubleantigensoftype specificity.
The significance of these antigens in
relation to those previously defined for
" wild " type murine leukaemias will be
discussed.
HOST IMMUNE RESPONSES IN
B.C.G. THERAPY OF A RAT OSTEO-
SARCOMA, N. Lawrence and M. Moore,
Charles Salt Research Centre, The Robert
Jones and Agnes Hunt Orthopaedic Hospital,
Oswestry.
The growth of syngeneic grafts of tumour
cells is suppressed when cells are mixed with
B.C.G. before inoculation, or if clinically
established nodules are infiltrated with
microorganisms. Theoretically, three types
of processes operating individually or in
combination might account for this pheno-
menon: (i) non-immune effects; (ii) B.C.G.
immunity and (iii) tumour immunity.
In experiments performed with an immu-
nogenic, chemically induced osteosarcoma,
growth inhibition by B.C.G. was less effective
in rats immunosuppressed by thymectomy
and irradiation than in their immunocom-
petent counterparts. In the study of the
respective roles of immunity to tumour and
B.C.G., the differential radiosensitivity of
primary and secondary immunity permitted
the evaluation of the effect of immunity to
one antigen on a second antigen, to which
primary immunity had been prevented by
interim irradiation.
Evidence will be presented to show that
the host response to B.C.G. is essentially
local and immunological. Tumour out-
growth from B.C.G. tumour cell inocula
occurred with greater frequency in rats
prevented from responding to tumour antigen
than in normal recipients, suggesting that
while local immune reactivity to B.C.G. is a
necessary component of successful tumour
growth inhibition, it is not invariably suffi-
cient.
TUMOUR THERAPY IN DOGS USING
B.C.G., L. N. Owen and D. E. Bostock,
Department of Animal Pathology, School of
Veterinary Medicine, University of Cam-
bridge.
Experimental dogs have been injected
intradermally, intravenously, intrathoracic-
ally and intraperitoneally with percutaneous
B.C.G. vaccine (Glaxo).
Following i.v. injection a patchy inter-
stitial pneumonia has been found with
small granulomata in lungs and liver. There
is lymph node hyperplasia. A small and
transient rise in temperature occurs.
Dogs with osteosarcoma treated surgically
or by x-irradiation have been injected i.v.
with B.C.G. alone or B.C.G. and autologous
tumour cells. Results are encouraging.
Dogs with lymphosarcoma treated by chemo-
therapy and followed by intravenous B.C.G.
alone have not responded well.
Two dogs, one lymphosarcoma and one
osteosarcoma, had anaphylactic shock after
the second B.C.G. injection and an anti-
histamine drug is now routinely given before
the B.C.G.
IMMUNOLOGICAL MECHANISMS IN
CONTROL OF MALIGNANT DI-
SEASE, C. Bone and R. S. Camplejohn,
Departments of Surgery and Pathology,
University of Newcastle upon Tyne.
Cellular immune mechanisms have often
been implicated as important factors in the
restriction and control of neoplastic pro-
liferation. A study wasplannedtoinvestigate
the relationship between cellular immunity,
the rate of malignant cell proliferation and
prognosis in 40 patients with carcinoma of
the rectum.
Cellular immunity was measured by
assessing the patients' delayed hypersensi-
tivity responses to 2-4 dinitrochlorobenzene
(DNCB). The proliferation rates ofthe rectal
carcinomata and the mucosa from which
they arose were measured using an in vivo
stathmokinetic technique (Refsum and Ber-
dal, Tidskr. norske Laegeforen., 1968, 126.
1224).
Each tumour was staged according to its
size and evidence of lymphatic involvement
or metastases. The patients' clinical progress
was followed.
It was found that there was highly signi-
ficant (P > 0-001) relationship between com-
petent cellular immunity and favourable
prognosis. It was also foundthatthe prolifera-
tion rate of the rectal carcinomata was only
halfthat ofthe mucosa from which they arose
and growth was due to a diminished cell loss.
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